Recent Updates
Recently added Catalysts

RAPT Therapeutics, Inc.

RAPTFDA catalysts, PDUFA dates & pipeline intelligence
$58.02
▲ +0.04 · +0.07%

Last traded Mar 2, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full RAPT financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $5.6752W HIGH $58.02
Volume
11.13 M
Value Traded
645.21 M
Short % Float
22.48%
Days to Cover
1.4
+0.21%Week
+0.66%1 Month
+84.07%3 Month
+391.28%6 Month
-62.75%5 Year
-40.8%All Time

Cash Data

Unlock RAPT cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.61 B
EPS (TTM)
-11.07
P/E Ratio
-
Ent. Value
1.45 B
Total Shares
16.51 M
Float Shares
5.96 M
Insiders
48.80%
Institutions
66.35%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Phase 2 data readout
RPT-904
food allergy
Phase 2bSmall MoleculesImmunology
Unlock every RAPT catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

RAPT Catalyst Timeline

Dated clinical, regulatory and corporate events for RAPT Therapeutics, Inc.

Unlock the full RAPT catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How RAPT actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all RAPT historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
3
Drugs Scored
rNPV / MCap
Top Drug
Showing 3 of 4 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
RPT904 Small moleculeNCT07220811Ig-E Mediated Food AllergyPhase 2 RECRUITING 100Jan 1, 2028
FLX475 Small moleculeCompletedNCT03674567Advanced CancerPhase 1/2 COMPLETED 323Dec 31, 2024
14C RPT193 Small moleculeCompletedNCT06087978UndisclosedPhase 1 COMPLETED 7Oct 12, 2023
Unlock the RAPT pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every RAPT program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
RPT904 Chronic Spontaneous UrticariaPhase 22025-10-20mean baseline UAS7 scores: Q8W 28.7 (±7.2), Q12W 28.9 (±6.6), Q4W 28.8 (±7.9)Read MoreRAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous UrticariaRead More
Scroll for more · summaries link to the source press release
Unlock every RAPT trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock RAPT insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Brockstedt Dirk G.Officer (CHIEF SCIENTIFIC OFFICER)Sell -898 27,820 held$22.78 01/05/2024
Unlock the full RAPT insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in RAPT

Fund % of Portfolio Current MV Shares Owned Activity
TCG Crossover Management, LLC 2.9 % (38.1 %) 87.47 M 2.58 M 57.82% ( 946.13 K)
Unlock every fund holding RAPT
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in RAPT
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see RAPT ownership
Insider and institutional ownership, quarter by quarter.

RAPT Short Interest

Shares sold short, counted twice a month.

22.48%
Short % of Float
of tradable shares sold short
1.3M
Shares Sold Short
-40.2% vs prior count
1.4 Low
Days to Cover
trading days of normal volume to buy every short share back
964.9K
Avg Daily Volume
the average used for days to cover
Unlock RAPT short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock RAPT option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live RAPT option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock RAPT options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How RAPT ranks across every disease it competes in

Competitive Position is a premium feature
See how RAPT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

RAPT News

About RAPT Therapeutics, Inc.

Founded2015
BIOPHARMAWATCH ELITE PLUS
Trade the next RAPT catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime